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Purpose: To compare factors affecting patient satisfaction after femtosecond laser in situ 
keratomileusis (FS-LASIK) and small incision lenticule extraction (SMILE) for myopia in the 
real-life situation study.
Methods: The SMILE group included 100 eyes (51 patients) and the FS-LASIK group 200 eyes 
(102 patients). In addition to clinical examination, dry eye symptoms and patient satisfaction 
with far and near vision were reported and graded on the visual analog scale preoperatively 
and one month after the operation. Case–control pairs were selected for the SMILE patients 
from FS-LASIK-treated patients to ensure the homogeneity in spherical equivalent refraction, 
preoperative dry eye, and visual satisfaction.
Results: Eighty percent of SMILE eyes and 83% of FS-LASIK eyes achieved an uncor-
rected distance visual acuity of 20/20 or better. Predictability (±0.5 D of mean target spherical 
equivalent refraction) was 91% in SMILE and 93.5% in FS-LASIK. No eyes lost two or more 
Snellen lines of corrected distance visual acuity. Based on case–control pairs, dry eye symptoms 
remained the same after one month in the FS-LASIK-treated eyes (P=0.87) but decreased in the 
SMILE-treated eyes (P=0.01) compared with the preoperative situation. Patient satisfaction with 
far vision improved significantly in both groups (P0.001), but satisfaction with near vision 
improved significantly only in FS-LASIK (P0.001) and not in SMILE (P=0.58). There was 
more postoperative astigmatism in SMILE in comparison with FS-LASIK (P=0.002).
Conclusions: In a real-life situation, patients with preoperative dry eye experience were 
often directed to the SMILE operation, which resulted in beneficial decrease in their dry eye 
symptoms. Patient satisfaction with far vision decreased with increasing dry eye symptoms and 
postoperative astigmatism in both SMILE- and FS-LASIK-treated emmetropic patients. Safety, 
efficacy, and predictability were comparable in both treatments.
Keywords: femtosecond laser in situ keratomileusis, FS-LASIK, small incision lenticule 
extraction, SMILE, dry eye, patient satisfaction, myopia, astigmatism
Plain language summary
Dr Pietilä’s team in Finland investigated patient satisfaction and dry eye symptoms in two 
different types of refractive eye surgery. The most widely used refractive surgery to improve 
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vision and to replace the use of spectacles or contact lenses is laser 
in situ keratomileusis (LASIK), in which a hinged flap is created in 
the cornea of the eye either with a mechanical microkeratome or with 
a femtosecond laser (FS-LASIK). The exposed part of the cornea is 
reshaped with the excimer laser and the flap is repositioned. Small 
incision lenticule extraction (SMILE) is a more recent refractive 
surgery in which the cornea of the eye is reshaped by creating a 
removable small lenticule inside the cornea with the femtosecond 
laser. In addition to the clinical examination of the eyes before the 
operation and one month after the surgery, the patients rated their 
dry eye experience as well as far and near vision satisfaction by 
using visual analog scale grading. FS-LASIK and SMILE seemed 
comparable based on clinical evaluations. In the real-life situation, 
patients with preoperative dry eye experience were directed to the 
SMILE operation, which resulted in beneficial decrease in their dry 
eye symptoms. Patient satisfaction with far vision improved signifi-
cantly in both FS-LASIK and SMILE: FS-LASIK-treated patients 
were more satisfied with the improvement of their near vision than 
SMILE-treated patients. FS-LASIK-treated patients had also less 
astigmatism vision than SMILE-treated patients.
Introduction
Small incision lenticule extraction (SMILE) is a novel tech-
nique used to correct refractive errors using only one type of 
laser, the femtosecond laser, for the complete operation. Con-
trary to femtosecond laser in situ keratomileusis (FS-LASIK), 
no corneal flap is created; instead, an intrastromal lenticule is 
removed through a small incision.1,2 Theoretically, SMILE is 
a less invasive procedure because of the absence of flap cut-
ting and thus affecting less subbasal corneal nerves and ocular 
surface parameters, such as tear volume, corneal sensitivity, 
and subjective symptoms after refractive surgery.
Corneal refractive surgeons report dry eyes as the most 
common complication of LASIK.3 According to the definition 
of the Dry Eye Workshop, dry eye disease is a multifunctional 
pathology at the ocular surface, which includes tear film 
changes with or without corneal damage, ocular symptoms, 
visual degradation, and increased tear osmolarity, together 
leading to the degradation of the quality of life.4 Immediately 
after LASIK, up to 95% of patients report some dry eye 
symptoms; however, these are usually transient in nature.5 
LASIK-associated dry eye symptoms are also the main reason 
for patient dissatisfaction.6 It has been estimated that SMILE 
may reduce not only complications associated with flap cut-
ting and epithelial ingrowth but also dry eye symptoms and 
thus increase patient satisfaction.7 Recent meta-analyses 
have indicated that FS-LASIK-treated myopic eyes suffer 
more severely from dry eye symptoms than SMILE-treated 
eyes.8–11 According to one recent meta-analysis, SMILE 
does not show superiority over FS-LASIK with similar 
and acceptable objective parameters, but SMILE may have 
milder subjective symptoms.12 In this study, we investigated 
the factors affecting patient satisfaction in subjects who 
underwent FS-LASIK or SMILE for myopic eyes. Dry eye 
symptoms and patient satisfaction were reported in this 
real-life situation study in the self-questionnaire based on 
the visual analog scale (VAS) grading. To ensure the homo-
geneity of the samples, a case–control subgroup from the 
FS-LASIK-treated eyes was created based on preoperative 
patient satisfaction and dry eye symptoms in order to find a 
match for SMILE-treated eyes.
Patients and methods
This retrospective, nonrandomized comparative study 
involved 153 patients (87 females and 66 males, 300 eyes) 
who were scheduled for refractive correction at two 
Silmäasema Eye Hospitals in Tampere and Helsinki (Finland) 
from May to October 2016. We have used the patient data-
base, refractive surgery technical data, and quality control 
data of patient satisfaction of these two Silmäasema Eye 
Hospitals for the study. According to the EU legislation, ret-
rospective analyses of existing data do not need the approval 
of an ethics committee. The data used were deidentified. The 
study included 100 eyes (51 patients) in the SMILE group 
and 200 eyes (102 patients) in the FS-LASIK group. The 
selection of the procedure type was based on the patient’s 
own preference for the treatment and the discussion with the 
operating surgeon (JP) corresponding to a real-life setting at 
the time of the study.
Preoperative examinations
All patients had a complete preoperative ophthalmologic 
examination before the FS-LASIK or SMILE surgery to 
exclude any contraindication for the surgery, such as corneal 
ectasia or retinal or lenticular pathology. The examination 
included biomicroscopy, the measurement of corneal thick-
ness and three-dimensional corneal topography (Allegro 
Oculyzer, WaveLight AG, Erlangen, Germany), the deter-
mination of refraction, the measurements of uncorrected 
and corrected distance visual acuity (UDVA and CDVA, 
respectively), the measurement of intraocular pressure (iCare 
TA01i, iCare Finland Oy, Vantaa, Finland), and wavefront 
analysis (Allegro Analyzer, WaveLight AG). Patients had to 
discontinue wearing soft contact lenses for at least one week 
before the treatment.
surgical techniques
All surgical procedures were performed by a single surgeon 
(JP). The following drops were instilled into the eyes prior 
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to the surgery: antibiotic eye drops, levofloxacin 5 mg/mL 
(Oftaquix, Santen Oy, Tampere, Finland); for pain and 
inflammation, diclofenac 1 mg/mL (Voltaren Ophtha, 
THEA, Clermont-Ferrand, France); to constrict conjunctival 
vessels, brimonidine tartrate 2 mg/mL (Alphagan, Allergan, 
Westport, Ireland); and topical anesthetic, oxybuprocaine 
hydrochloride 4 mg/mL (Oftan Obucain, Santen Oy). 
An aspirating speculum (no 15961, Geuder, Heidelberg, 
Germany) was used to open the eyelid.
Fs-lasiK technique
For flap creation in the FS-LASIK, the FEMTO LDV Z6 
I femtosecond laser (Ziemer Ophthalmic Systems, Port, 
Switzerland) was used in Tampere (79 patients, 156 eyes) 
and the VisuMax® femtosecond laser (Carl Zeiss Meditec 
AG, Jena, Germany) in Helsinki (23 patients, 44 eyes). 
The FEMTO LDV Z6 I delivered 100 nJ pulse energy and 
10 MHz repetition rate. The target flap thickness ranged 
from 90 to 100 µm. All flaps were roundly shaped and 
set from 60° to 90° angled edge. A plastic single-use 
suction ring with the 9.5 mm diameter was used with the 
target flap diameter of 9.3 mm. The target hinge length 
was 4.0 mm. The vacuum pressure was 700 mbar and 
the cutting time 28 seconds. In the VisuMax, the target 
flap thickness was also ranging from 90 to 100 µm, the 
flap diameter was 8.9 mm, and the S glass was used. 
The flaps were set at 60° angled edge, and the target hinge 
length was 3.8 mm. The cutting time was 18 seconds. In 
both cases, the excimer laser treatment was done on the 
exposed stroma using the WaveLight EX500 excimer 
laser (WaveLight AG).
sMile technique
In the flap-free SMILE surgery, the VisuMax femtosec-
ond laser was used to create an intrastromal lenticule. The 
VisuMax had a repetition rate of 500 kHz and a pulse energy 
of 130 nJ. The cap thickness was 120 µm and the cap diam-
eter 7.9 mm. The optical zone varied from 6.5 to 7.0 mm. 
The laser created a peripheral corneal incision from 2.8 to 
3.0 mm. The incision site was at 11–12 o’clock. Special 
SMILE forceps were used to go through the incision and 
remove the lenticule.
Postoperative treatment
In both FS-LASIK and SMILE, chloramphenicol and dex-
amethasone containing drops (Oftan Dexa-Chlora, Santen 
Oy) were used for the first week with the tapered dose. On 
the day of the surgery, drops were used every two hours, on 
the following day every three hours five times daily. On the 
third and fourth day, drops were used four times daily, and 
on the fifth and sixth day, three times daily, and on the 
seventh day two times daily. Artificial tear drops were used 
as needed after the surgery for the following month. Gel-
like moisturizing eye drops were used for the night day and 
every morning. The frequency of using artificial tears was 
not monitored in this study.
Follow-up examinations
On the one-month follow-up visit, UDVA, CDVA, and 
refraction were tested; clinical examination was performed; 
and a patient questionnaire was filled in.
Patient questionnaire
Patients were given a subjective questionnaire preopera-
tively and one month after the operation to rate their dry 
eye symptoms and satisfaction with far vision and near 
vision separately. Dry eye symptoms were graded on the 
VAS from 0 (no dryness) to 10 (extremely dry eyes). The 
patients were also asked to rate their satisfaction with both 
far vision and near vision on the VAS from 0% (poor) to 
100% (excellent). The patients were asked to mark their 
response on the vertical line, at the point of their choice, and 
the length of the line segment was measured and recorded 
for analysis.
In the cases when both eyes were treated with either FS-
LASIK or SMILE, in emmetropia both eyes had 0 as a target 
sphere. In monovision, one eye had 0 as a target sphere while 
the other eye had a myopic target sphere (max -1.50 D). All 
complications during FS-LASIK and SMILE procedures and 
at one-month follow-up time were recorded.
statistical methods
All measured data were collected and entered into standard-
ized study spreadsheets of Excel 2016 (Microsoft Corpora-
tion, Redmond, WA, USA). Values were given as mean ± 
standard deviation. The independent Student’s t-tests were 
used to compare data between the SMILE and FS-LASIK 
groups, and the paired Student’s t-tests were used for statisti-
cal analysis to compare data before and after the treatment 
for a given group. The chi-squared test, the Fisher’s exact 
test, or the mixed-effect model was used to compare the study 
group frequencies or repeated measures.
The FS-LASIK–SMILE (case–control) pairs were cre-
ated by matching each individual SMILE patient with an 
FS-LASIK patient with the most similar attempted cor-
rection, preoperative dry eye sensation, and preoperative 
patient satisfaction with near and far vision. The similarity 
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of a given SMILE patient and available FS-LASIK patients 
was evaluated by generating a Euclidean distance matrix. 
Then by locating the smallest distance measure from the 
matrix, the FS-LASIK–SMILE pair with the most similar 
attempted correction, preoperative dry eye sensation, and 
preoperative patient satisfaction with near and far vision 
could be obtained.
Linear regression was used to analyze the relationship 
between different parameters. We made correlations with 
dry eye symptoms and patient satisfaction with the case–
control pair data using the following factors: preoperative 
and postoperative spherical equivalent (SEQ) refraction, 
postoperative UDVA, postoperative cylinder, and patient 
age. For each patient, the eye with a better postoperative 
UDVA was chosen.
Statistical tests were performed with the GraphPad Prism 
software (La Jolla, CA, USA). A P-value 0.05 was consid-
ered statistically significant. The R software version 3.3.1 (R 
Core Team, R Foundation for Statistical Computing, Vienna, 
Austria) was used to match the case–control pairs. Figures 
were created with the SigmaPlot software (Systat Software, 
San Jose, CA, USA).
Results
Altogether 153 patients underwent refractive surgery for 
myopia resulting in 300 operated eyes. The age of the patients 
ranged from 18 to 54 years (mean age: 34.1±7.7 years). There 
were 100 eyes (51 patients) in the SMILE group and 200 eyes 
(102 patients) in the FS-LASIK group (Table 1). All patients 
completed the one-month follow-up examination (Table 2).
refraction
The preoperative mean SEQ refraction was -4.08±1.65 D 
(range: -1.38 to -8.25 D) in the SMILE group and -4.37±2.28 D 
(range: -0.63 to -11.63 D) in the FS-LASIK group 
(Figures 1 and 2). The postoperative mean SEQ refraction 
was -0.07±0.45 D (range: -1.75 to +0.75 D) and -0.06±0.52 D 
(range: -1.75 to +1.25 D) in the SMILE and FS-LASIK 
groups, respectively.
Efficacy, predictability, and safety
Postoperatively, 80 (80%) of all eyes in the SMILE group 
achieved a UDVA of 20/20 or better. The corresponding 
value for the FS-LASIK group was 166 (83%). Figures 1A 
and 2A show the preoperative cumulative Snellen CDVA 
in comparison with one-month postoperative UDVA in 
SMILE- and FS-LASIK-treated eyes with the plano target. 
When only the plano target was taken into consideration, in 
SMILE-treated eyes the efficacy was 85% and in FS-LASIK-
treated eyes 94%. With the plano target, UDVA was within 
one line of CDVA in 96.3% of SMILE-treated eyes and 
in 98.7% of FS-LASIK-treated eyes (Figures 1B and 2B). 
One month postoperatively, no eyes in the FS-LASIK group 
had lost any Snellen lines CDVA and two eyes (2%) in the 
SMILE group lost one line of CDVA (P=0.11; Figures 1C 
and 2C). One of these eyes had a slower recovery achiev-
ing the 20/20 of UDVA at 3 months postoperatively. The 
other, however, had not recovered after six months. The 
slower recovery of CDVA or the loss of it was not related 
to any recorded complications. At one month, the refrac-
tion was within ±0.5 D of mean target SEQ refraction in 
Table 1 Preoperative patient data
Variable SMILE
N=100 eyes
FS-LASIK
N=200 eyes
P-value
Number of patients (female/male) 51 (26/25) 102 (61/41) 0.30a
Age (year) 33.4±7.2 (range: 20 to 52) 34.4±7.9 (range: 18 to 54) 0.45
Sphere (D) -3.81±1.63 (range: -1.25 to -8.00) -3.98±2.27 (range: -11.50 to 0.0) 0.61b
Cylinder (D) -0.55±0.45 (range: 0.0 to -1.75) -0.79±0.70 (range:  0.0 to -3.25) 0.04b
Spherical equivalent (D) -4.08±1.65 (range: -1.38 to -8.25) -4.37±2.28 (range: -0.63 to -11.63) 0.40b
Keratometric power K1 (D) 43.30±1.20 43.31±1.39 0.93b
Keratometric power K2 (D) 44.20±1.33 44.29±1.43 0.76b
Central corneal thickness (µm) 556.7±32.8 548.7±32.7 0.20b
Dry eye sensation 3.78±2.46 (range: 0.5 to 9.5) (N=51 all patients) 2.75±1.92 (range: 0 to 9.0) (N=102 patients) 0.01
Patient satisfaction, far vision (%) 80.29±13.85 (range: 30 to 98) (N=51 patients)
79.72±13.27 (N=32 emmetropia)
81.26±15.09 (N=19 monovision)
73.10±21.28 (range: 10 to 99) (N=102 patients)
71.75±21.84 (N=56 emmetropia)
74.74±20.69 (N=46 monovision)
0.01
0.04
0.16
Patient satisfaction, near vision (%) 88.04±13.77 (range: 28 to 100) (N=51 patients)
90.03±11.08 (N=32 emmetropia)
84.68±17.22 (N=19 monovision)
82.36±20.44 (range: 11 to 100) (N=102 patients)
88.05±16.40 (N=56 emmetropia)
75.43±22.80 (N=46 monovision)
0.04
0.50
0.08
Notes: Values are presented as mean ± SD. Values shown in bold are statistically significant. P-values calculated with the student’s unpaired t-test, except for the following: 
achi-squared test; bmixed-effects model.
Abbreviations: Fs-lasiK, femtosecond laser in situ keratomileusis; sMile, small incision lenticule extraction.
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91 (91%) eyes in the SMILE group and 187 (93.5%) in the 
FS-LASIK group (Figures 1E and 2E). The postoperative 
astigmatism is presented in Figures 1F and 2F for SMILE- 
and FS-LASIK-treated eyes, respectively. Postoperative 
astigmatism in SMILE-treated patients was -0.22±0.29 D 
and in FS-LASIK-treated patients -0.07±0.17 (P=0.0012). 
The target-induced astigmatism vs surgically induced 
astigmatism is presented in Figures 1G and 2G for SMILE 
and FS-LASIK, respectively. The refractive astigmatism 
angle of error for SMILE and FS-LASIK is presented in 
Figures 1H and 2H, respectively.
Patient questionnaire results for all patients
The preoperative mean score of the subjective questionnaire 
for dry eye sensation was 2.75±1.92 in the FS-LASIK group. 
The dry eye sensation increased significantly (P=0.009) post-
operatively in the FS-LASIK group (3.35±2.20; Figure 3A). 
In the SMILE group, the preoperative dry eye sensation 
(3.78±2.46) decreased significantly (P=0.01) compared with 
the postoperative dry eye sensation (2.80±1.76).
Patient satisfaction with far vision improved significantly 
in both groups; FS-LASIK-treated eyes improved from 
73.10±21.28 to 90.18±13.59 (P0.001) and SMILE-treated 
from 80.29±13.85 to 89.84±12.42 (P0.001; Figure 3B). 
The mean score for patient satisfaction with near vision 
improved significantly in the FS-LASIK-treated eyes (from 
82.36±20.44 to 91.20±12.09, P0.001; Figure 3C). In the 
SMILE-treated patients, there was no significant change in 
patient satisfaction with near vision (from 88.04±13.77 to 
89.31±11.37, P=0.57).
Patient questionnaire results for case–
control pairs
The patients undergoing a SMILE or LASIK surgery had 
differences in their preoperative dry eye experiences. Patients 
with stronger preoperative dry eye symptoms preferred 
SMILE (P=0.011). Therefore, to ensure the homogeneity 
of our study, 51 case–control pairs were chosen from the 
FS-LASIK group to match with the SMILE group based on 
attempted correction, preoperative dry eye symptoms, and 
Table 2 Postoperative 1-month variables
Variable SMILE
N=100 eyes
FS-LASIK
N=200 eyes
P-value
Sphere (D) 0.04±0.48
(range: -1.75 to +1.00)
-0.03±0.52
(range: -1.75 to +1.75)
0.33a
Cylinder (D) -0.22±0.29
(range: -1.25 to 0.0)
-0.07±0.17
(range: -1.00 to 0.0)
0.0012a
Spherical equivalent refraction (D) -0.07±0.45
(range: -1.75 to +0.75)
-0.06±0.52
(range: -1.75 to +1.25)
0.91a
Efficacy (%) 80.00 (80/100) 83.00 (166/200) 0.52b
Efficacy, plano target (%) 85.19 (69/81) 93.51 (144/154) 0.64b
Predictability (%) 91.00 (91/100) 93.50 (187/200) 0.43b
Safety, loss of one or more Snellen lines of CDVA (%) 2.00 (2/100) 0 (0/200) 0.11c
Dry eye sensation 2.80±1.76
(range: 0.2 to 8.0)
(N=51 all patients)
3.35±2.20
(range: 0 to 9.8)
(N=102 patients)
0.10
Patient satisfaction, far vision (%) 89.84±12.42
(range: 44 to 100)
(N=51 all patients)
89.03±14.47
(N=32 emmetropia)
91.21±8.06
(N=19 monovision)
90.18±13.59
(range: 22 to 100)
(N=102 all patients)
90.27±15.82
(N=56 emmetropia)
90.07±10.41
(N=46 monovision)
0.88
0.71
0.64
Patient satisfaction, near vision (%) 89.31±11.37
(range: 47 to 100)
(N=51 all patients)
90.66±12.06
(N=32 emmetropia)
87.05±10.01
(N=19 monovision)
91.20±12.09
(range: 15 to 100)
(N=102 all patients)
94.44±7.94
(N=56 emmetropia)
87.24±14.89
(N=46 monovision)
0.35
0.12
0.95
Notes: Values are presented as mean ± standard deviation. Values shown in bold are statistically significant. P-values calculated with the student’s unpaired t-test, except for 
the following: amixed-effects model; bchi-squared test; cFisher’s exact test.
Abbreviations: CDVa, corrected distance visual acuity; Fs-lasiK, femtosecond laser in situ keratomileusis; sMile, small incision lenticule extraction.
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Figure 1 (Continued)
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preoperative patient satisfaction with far and near vision. For 
each patient, the eye with a better postoperative UDVA was 
chosen. The SMILE data had 26 females and 25 males, and 
the FS-LASIK data resulted with 36 females and 15 males. 
Of the 51 patients in both groups, 32 eyes had emmetropic 
correction and 19 eyes had a specific monovision correction. 
The age was 33.41±7.16 years in the SMILE group and 
33.6±8.47 years in the FS-LASIK group (P=0.9). The amount 
of attempted correction was -4.06±1.66 D in the SMILE 
group and -4.42±2.11 in the FS-LASIK group (P=0.33). 
We noted that postoperative cylinder was larger in SMILE-
treated patients (-0.17±0.20 D) than in FS-LASIK-treated 
patients (-0.06±0.13 D; P=0.002).
After adjusting the case–control pairs, the preoperative 
dry eye experience was very similar; 3.78±2.46 in the SMILE 
group and 3.41±2.23 in the FS-LASIK group (P=0.43). This 
relatively high level of dry eye experience was decreased 
significantly in the SMILE group (-0.98±2.77; P=0.01) but 
not in the FS-LASIK group (-0.05±2.12; P=0.87) after the 
operation (Figure 3A). Patient satisfaction with far vision 
improved significantly in FS-LASIK-treated eyes from 
79.82±15.01 to 93.0±9.29 (P0.001) and in SMILE-treated 
from 80.29±13.85 to 89.84±12.42 (P0.001; Figure 3B). 
The mean score for patient satisfaction with near vision 
improved significantly in the FS-LASIK-treated eyes (from 
88.2±12.44 to 93.22±8.81; P0.001) but not in SMILE-
treated eyes (from 88.04±13.77 to 89.31±11.37, P=0.58; 
Figure 3C).
Correlation figures of case–control patients for postopera-
tive dry eye symptoms and patient satisfaction with far and near 
vision are presented in Figure S1. Patient satisfaction with far 
vision was negatively correlated with postoperative dry eye 
experience (r=-0.36, P=0.046; Figure S1A) and postoperative 
astigmatism (r=-0.51, P=0.003; Figure S1B) in FS-LASIK-
treated emmetropic patients. The same correlation was found 
in SMILE-treated emmetropic patients: dry eye experience 
(r=-0.46, P=0.01; Figure S1C) and postoperative astigmatism 
(r=-0.47, P=0.01; Figure S1D). In addition, we found a posi-
tive correlation in far vision satisfaction with postoperative 
SEQ refraction (r=0.42, P=0.02; Figure S1E) and postopera-
tive UDVA (r=0.49, P=0.004; Figure S1F) in SMILE-treated 
emmetropic eyes. In SMILE-treated monovision patients, 
patient satisfaction with far vision also positively correlated 
with postoperative UDVA (r=0.49, P=0.03; Figure S1G) and 
in FS-LASIK-treated monovision patients with postoperative 
SEQ refraction (r=0.58, P=0.01; Figure S1H). In SMILE-
treated emmetropic patients, patient satisfaction with near 
vision correlated negatively with postoperative astigmatism 
(r=-0.55, P0.001; Figure S1I) and positively with postop-
erative UDVA (r=0.39, P=0.03; Figure S1J). In FS-LASIK-
treated monovision patients, patient satisfaction with near 
vision correlated negatively with age (r=-0.81, P0.0001; 
Figure S1K) and positively with postoperative UDVA (r=0.47, 
P=0.04; Figure S1L). In FS-LASIK-treated emmetropic 
patients, postoperative dry eye experience correlated negatively 
with postoperative UDVA (r=-0.39, P=0.03; Figure S1M).
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Figure 1 standard graphs for reporting refractive surgery outcomes in sMile-treated eyes.
Notes: (A) UDVA; (B) UDVA vs CDVA; (C) change in CDVA; (D) SEQ refraction attempted vs achieved; (E) SEQ refraction accuracty; (F) refractive astigmatism; (G) TIA 
vs SIA; and (H) refractive astigmatism angle of error. In D and G, the values were according to the green line within 0.5 D and the pink line within 1.0 D.
Abbreviations: CC/wise, counterclockwise; C/wise, clockwise; CDVA, corrected distance visual acuity; postop, postoperative; preop, preoperative; SEQ, spherical equivalent 
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Complications
In the SMILE group, one eye had a suction loss. The eye was 
redocked, and the procedure was completed. Furthermore, 
in the SMILE-treated eyes, wrinkles appeared in two caps. 
In the FS-LASIK group, the Barraquer eye speculum was 
used in four eyes, canthotomy was done in one eye, and a 
decentered flap was observed in one eye. None of the com-
plications appeared to affect visual acuity.
Discussion
In the present study, FS-LASIK- and SMILE-treated eyes 
were comparable in terms of efficacy, predictability, and 
safety. This is in good accordance with the previously pub-
lished literature.8–12 Since 2016, five meta-analyses8–12 have 
been conducted to assess possible differences in clinical 
outcomes when FS-LASIK and SMILE were used to correct 
myopia and myopic astigmatism, showing that FS-LASIK 
and SMILE were comparable in terms of efficacy, predict-
ability, and safety.8,9 However, it is noteworthy that there 
are only few studies, which have been conducted on patient 
satisfaction and dry eye symptoms with a self-reporting 
questionnaire.13–19 Therefore, we investigated patients’ dry 
eye experience and patient satisfaction with far and near 
vision using a self-questionnaire based on the VAS grading 
in the real-life situation. To ensure the homogeneity of the 
data, we formed case–control pairs with respect to attempted 
correction, preoperative dry eye sensation, and preoperative 
patient satisfaction to further evaluate the differences in FS-
LASIK and SMILE. To the best of our knowledge, the current 
study is the first to investigate the clinical factors affecting 
patient satisfaction after SMILE and FS-LASIK.
There were no significant differences in the change of 
patient satisfaction with far vision between SMILE and 
FS-LASIK. However, patient satisfaction with near vision 
was better in FS-LASIK-treated eyes than in SMILE-treated 
patients. In FS-LASIK-treated presbyopic monovision 
patients, satisfaction with near vision decreased with age. 
SMILE-treated eyes had more postoperative astigmatism 
than FS-LASIK-treated eyes.
The self-reported dry eye sensation and postop-
erative astigmatism appeared to be major determinants of 
patient satisfaction with far vision. Both in SMILE- and 
FS-LASIK-treated emmetropic patients, satisfaction with 
far vision decreased with increasing dry eye symptoms 
and postoperative astigmatism. In SMILE-treated emme-
tropic patients, satisfaction with far vision also increased 
with increasing postoperative SEQ refraction and UDVA. 
In SMILE-treated emmetropic patients, patient satisfaction 
with near vision increased with increasing postoperative 
UDVA and decreased with increasing postoperative astig-
matism. Chan et al20 found in the low to moderate myopic 
astigmatism corrections the postoperative cylinder to be 
higher in the SMILE group than in the FS-LASIK group, 
which supports our results. However, Zhang et al21 found 
Figure 2 standard graphs for reporting refractive surgery outcomes in Fs-lasiK-treated eyes.
Notes: (A) UDVA; (B) UDVA vs CDVA; (C) change in CDVA; (D) SEQ refraction attempted vs achieved; (E) SEQ refraction accuracty; (F) refractive astigmatism; (G) TIA 
vs SIA; and (H) refractive astigmatism angle of error. In D and G, the values were according to the green line within 0.5 D and the pink line within 1.0 D.
Abbreviations: CC/wise, counterclockwise; C/wise, clockwise; CDVA, corrected distance visual acuity; FS-LASIK, femtosecond laser in situ keratomileusis; postop, postoperative; 
preop, preoperative; SEQ, spherical equivalent refraction; SIA, surgically induced astigmatism; TIA, target-induced astigmatism; UDVA, uncorrected distance visual acuity.
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no differences in the surgically induced astigmatism in 
moderate- to high-astigmatism corrections in SMILE and 
FS-LASIK. In our studies, we discovered that when the 
nomogram of the VisuMax was used, more astigmatism 
was detected; therefore, a customized nomogram should be 
used to reduce residual astigmatism. The correlation of the 
self-reported far vision satisfaction with the severity of dry 
eye symptoms could be explained, at least partly, by optical 
factors. Dry eye symptoms reflect the condition of the quality 
of the tear film, and thus, the optical quality of the anterior 
surface of the cornea. To improve patient satisfaction, an 
intensive use of artificial tears after the operation may thus 
be beneficial, especially for the FS-LASIK patients.
In the real-life situation, SMILE-treated patients benefit-
ted from the treatment by a decrease in dry eye symptoms. 
The decrease in dry eye symptoms may be related to the com-
monness of dry eye symptoms and the cessation of contact 
lens wear after the refractive surgery as contact lenses are 
known to induce discomfort and dry eye symptoms.22 The 
use of eye drops may have also helped to reduce the dry eye 
sensation after the refractive surgery. Previously published 
data on the comparison of SMILE and FS-LASIK have 
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Figure 3 Changes in dry eye symptoms, patient satisfaction with near and far vision one month after SMILE or FS-LASIK operation (before and after case–control 
filtering).
Notes: (A) Preoperative and one-month patient dry eye experience in SMILE and FS-LASIK on a scale of 0 (no dryness) to 10 (extremely dry eyes). (B) Preoperative and 
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Abbreviations: Fs-lasiK, femtosecond laser in situ keratomileusis; preop, preoperative; sMile, small incision lenticule extraction.
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shown that SMILE-treated eyes have less dry eye symptoms 
than FS-LASIK-treated eyes.13–18,23
Patients who have more preoperative dry eye symptoms 
often prefer the SMILE treatment rather than the FS-LASIK 
procedure. This is probably due to the information that 
they are given by health care providers and their friends, 
getting from the written media, and increasingly from the 
Internet and the social media. It was also evident in our 
study that the patients with more dry eye symptoms chose 
more often SMILE than FS-LASIK. To overcome this, we 
used a case–control pair strategy. Interestingly, among these 
case-controlled patients, the self-reported dry eye sensation 
after FS-LASIK remained the same while it increased in the 
original FS-LASIK group of all patients compared with the 
preoperative situation. This might be explained by the fact that 
when selecting case–control pairs for the SMILE patients we 
also selected the FS-LASIK patients having more and more 
severe dry eye symptoms (Figure 3A). One could speculate 
that there might have been some kind of a ceiling effect of 
dry eye symptoms after FS-LASIK that could have influenced 
the results. Patients having more severe preoperative dry eye 
symptoms did not report any more worsening symptoms after 
the operation. The constant, postoperative use of artificial 
tears has probably been one reason to this ceiling effect.
This study investigated patient satisfaction in the real-life 
setting using a simplified and quick self-questionnaire based 
on the VAS grading. Furthermore, we were able to make 
case–control pairs from our study groups to reduce the dif-
ferences in the patient groups. VASs are practical, efficient, 
and easy-to-use methods. There are, however, limitations, eg, 
responders often avoid the ends of the scale. Therefore, the 
linearity of the symptom scale at both ends of VAS scale might 
be a problem in this respect and in these regions may not be a 
valid reflection of the severity of the health state that is being 
estimated. There are also other limitations in the present study. 
We did not measure uncorrected near visual acuity. We also 
did not include any physiological measurements in the study, 
and the questionnaire could have been more well-established 
such as the Ocular Surface Disease Index. An elevated patient 
number could have strengthened the study. Finally, a longer 
follow-up time, for at least three to six months, would be 
advisable for more stable refractive outcomes.
Conclusions
FS-LASIK and SMILE were comparable in terms of effi-
cacy, predictability, and safety for the treatment of myopia. 
Subjective dry eye symptoms remained the same after 
one month compared with the preoperative situation, in 
the FS-LASIK-treated eyes, but decreased in the SMILE-
treated eyes. Patient satisfaction with far vision improved 
significantly in both study groups. Patient satisfaction with 
near vision improved significantly only in the FS-LASIK-
treated eyes. SMILE-treated eyes had more postoperative 
astigmatism than FS-LASIK-treated eyes. The self-reported 
dry eye sensation and postoperative astigmatism and UDVA 
appeared to be major determinants of patient satisfaction with 
far vision. In both techniques, the single major determinant 
of patient satisfaction seemed to be the accuracy of refrac-
tive correction.
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